title: Commentary on: "Focal cryosurgical ablation of the prostate: a single institute's perspective".
abstract: The morbidity of whole gland treatment for prostate cancer is significant. Given the low risk of prostate cancer specific mortality for most men diagnosed with prostate cancer, alternative therapies such as sub-total or hemi-ablation of the prostate and focal ablation of prostate tumors are being investigated. The developing role of imaging for prostate tumors will dramatically change and likely improve the treatment morbidity for low risk prostate tumors. Commentary on: http://www.biomedcentral.com/1471-2490/13/2.
authors.affiliation: Urologic Oncology Branch, National Cancer Institute, NIH, Building 10, Room 2W-5940, 10 Center Drive, MSC 1210, Bethesda, MD, USA. adam.metwalli@nih.gov
authors.forename: Adam R
authors.initials: AR
authors.lastname: Metwalli
authors.forename: Peter A
authors.initials: PA
authors.lastname: Pinto
mesh_terms: D000230:Adenocarcinoma / Q000601:surgery*; D003452:Cryosurgery / Q000379:methods*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D011468:Prostatectomy / Q000379:methods*; D011471:Prostatic Neoplasms / Q000601:surgery*
references.citation: Curr Opin Urol. 2012 Jul;22(4):328-35
references.pmid: 22647649
references.citation: Lancet Oncol. 2012 Jun;13(6):622-32
references.pmid: 22512844
references.citation: Eur Urol. 2012 Jul;62(1):55-63
references.pmid: 22445223
references.citation: Radiology. 2013 Jun;267(3):932-40
references.pmid: 23440319
references.citation: J Urol. 2009 Dec;182(6):2659-63
references.pmid: 19836804
references.citation: BJU Int. 2012 Dec;110(11 Pt B):E783-8
references.pmid: 23130821
references.citation: Radiol Clin North Am. 2012 Nov;50(6):1061-73
references.pmid: 23122038
references.citation: Eur Urol. 2013 Apr;63(4):618-22
references.pmid: 23265382
references.citation: BMC Urol. 2013 Jan 11;13:2
references.pmid: 23311921